Full text is available at the source.
A low-reaction mRNA vaccine reveals an immune pathway linked to side effects
Updated
Abstract
Essence
IL-1 signaling was linked to LNP-mRNA vaccine adverse reactions without appearing necessary for neutralizing antibody responses.
Evidence
Mechanistic mouse-model immune profiling and in vivo blockade studies were paired with a controlled human vaccine cohort measuring IL-1 pathway activation, fever severity, and neutralizing antibody titers.
Caveat
The human cohort supports correlation, while pathway causality and selective reduction of adverse reactions were mainly tested in mice.
Simplified
mRNA Technology